David A. Jenkins - 12 Feb 2026 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Role
Chairman of the Board and CEO, Director
Signature
/s/ David A Jenkins
Issuer symbol
VTAK
Transactions as of
12 Feb 2026
Net transactions value
$0
Form type
4
Filing time
18 Feb 2026, 16:16:13 UTC
Previous filing
20 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JENKINS DAVID A Chairman of the Board and CEO, Director 1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL /s/ David A Jenkins 18 Feb 2026 0001279803

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTAK Series J Preferred Stock Other +2,491 2,491 12 Feb 2026 Common Stock 1,596,983 $1.56 Direct F1, F2, F3, F4
transaction VTAK Series J Preferred Stock Other +6,998 6,998 12 Feb 2026 Common Stock 4,486,022 $1.56 See Footnote F1, F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K").
F2 Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K.
F3 Series J Preferred Stock has no expiration date.
F4 The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K.
F5 Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP.